Arkolith/Insider Trading/AVNS/Form 4

Holbrook Kerr

SVP, Chief Commercial OfficerAVANOS MEDICAL, INC. (AVNS) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2025Grant(A)23K—$099K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2025Grant(A)49K—$049K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001606498-25-000053) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML